Cargando…
Estimating Metastatic Risk of Pancreatic Ductal Adenocarcinoma at Single-Cell Resolution
Pancreatic ductal adenocarcinoma (PDAC) is characterized by intra-tumoral heterogeneity, and patients are always diagnosed after metastasis. Thus, finding out how to effectively estimate metastatic risk underlying PDAC is necessary. In this study, we proposed scMetR to evaluate the metastatic risk o...
Autores principales: | Chen, Sina, Zhou, Shunheng, Huang, Yu-e, Yuan, Mengqin, Lei, Wanyue, Chen, Jiahao, Lin, Kongxuan, Jiang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736800/ https://www.ncbi.nlm.nih.gov/pubmed/36499343 http://dx.doi.org/10.3390/ijms232315020 |
Ejemplares similares
-
scDR: Predicting Drug Response at Single-Cell Resolution
por: Lei, Wanyue, et al.
Publicado: (2023) -
The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018) -
Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020) -
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
por: Gautam, Shailendra K., et al.
Publicado: (2023) -
CTpathway: a CrossTalk-based pathway enrichment analysis method for cancer research
por: Liu, Haizhou, et al.
Publicado: (2022)